Department of Pediatrics

Training

• Neonatal Pharmacotherapy Fellowship, The Women's Hospital of Greensboro, 2006 - 2008

Licensure and Board Certification

• 2006 - 2019NC, Pharmacist license
• 2008 - 2020MO, Pharmacist license
• 2017 - 2024Board Certified Pediatric Pharmacotherapy Specialist

Recent Publications view all (45)

Publication Co-Authors

Alexandra Lahart

Nathalie El Ters

Jason Newland, M.D., M.Ed.

Phillip I. Tarr, M.D.

David A. Hunstad, M.D.

Barbara B. Warner, M.D., MSc

Jennifer A Wambach, M.D.

Thomas Ferkol, M.D.

Zachary A. Vesoulis, MD MSCI

Amit M Mathur, M.D., M.R.C.P.

Alexis M. Elward, M.D., M.P.H.

Rakesh Rao, M.D.

Washington University has a long tradition of collaboration amongst colleagues.The faculty above have co-authored publications with Christopher McPherson

1. Lahart AC, McPherson CC, Gerber JS, Warner BB, Lee BR, Newland JG. Application of an antibiotic spectrum index in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2019;40(10):1181-1183. doi:10.1017/ice.2019  PMID:31352907 
2. McPherson C. Pharmacotherapy for the Prevention of Bronchopulmonary Dysplasia: Can Anything Compete with Caffeine and Corticosteroids? Neonatal Netw. 2019;38(4):242-249. PMID:31470395 
3. Liviskie CJ, DeAvilla KM, Zeller BN, Najaf T, McPherson CC. Nicardipine for the Treatment of Neonatal Hypertension During Extracorporeal Membrane Oxygenation. Pediatr Cardiol. 2019;40(5):1041-1045. PMID:31065758 
4. Charron AC, Carl MA, Warner BB, Newland JG, McPherson CC. Determinants of Initial Antibiotic Duration in Very Low Birth Weight Neonates. Infect Dis Ther. 2019;8(2):209-217. doi:10.1007/s40121-019-0241-6  PMCID:PMC6522625  PMID:30825133 
5. Ryan RM, Keller RL, Poindexter BB, D'Angio CT, Shaw PA, Bellamy SL, Moore PE, McPherson C, Greenberg JM, PROP Investigators.. Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium. J Pediatr. 2019;208:148-155.e3. PMCID:PMC6486865  PMID:30857774 
6. Ryan RM, Feng R, Bazacliu C, Ferkol TW, Ren CL, Mariani TJ, Poindexter BB, Wang F, Moore PE, Prematurity and Respiratory Outcome Program (PROP) Investigators.. Black Race Is Associated with a Lower Risk of Bronchopulmonary Dysplasia. J Pediatr. 2019;207:130-135.e2. PMCID:PMC6458591  PMID:30612812 
7. McPherson C, Luecke CM, Liviskie CJ, Zeller BN, Vesoulis ZA. Acetaminophen Serum Concentrations in Infants Treated Intravenously for Patent Ductus Arteriosus. J Pediatr Pharmacol Ther. 2019;24(2):134-137. PMCID:PMC6478358  PMID:31019406 
8. Rostas SE, McPherson C. Intravenous Lipid Emulsions in Infants: Is Balanced Better? Neonatal Netw. 2019;38(1):39-45. PMID:30679255 
9. McPherson C. Premedication for Endotracheal Intubation in the Neonate. Neonatal Netw. 2018;37(4):238-247. PMID:30567922 
10. McPherson C, Wambach JA. Prevention and Treatment of Respiratory Distress Syndrome in Preterm Neonates. Neonatal Netw. 2018;37(3):169-177. PMID:29789058 
11. McPherson C, Liviskie C, Zeller B, Nelson MP, Newland JG. Antimicrobial Stewardship in Neonates: Challenges and Opportunities. Neonatal Netw. 2018;37(2):116-123. PMID:29615159 
12. McPherson C, Lee BR, Terrill C, Hersh AL, Gerber JS, Kronman MP, Newland JG. Characteristics of Pediatric Antimicrobial Stewardship Programs: Current Status of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative. Antibiotics (Basel). 2018;7(1). PMCID:PMC5872115  PMID:29370071 
13. Rostas SE, McPherson C. Acid Suppression for Gastroesophageal Reflux Disease in Infants. Neonatal Netw. 2018;37(1):33-41. PMID:29436357 
14. Luecke CM, Liviskie CJ, Zeller BN, Vesoulis ZA, McPherson C. Acetaminophen for Patent Ductus Arteriosus in Extremely Low-Birth-Weight Neonates. J Pediatr Pharmacol Ther. 2017;22(6):461-466. PMCID:PMC5736259  PMID:29290747 
15. McPherson C, Inder T. Perinatal and neonatal use of sedation and analgesia. Semin Fetal Neonatal Med. 2017;22(5):314-320. PMID:28734732 
16. Liviskie CJ, Lange SA, McPherson CC. Precipitation of Heparin Products With Calcium Gluconate: The Activity of Inactive Ingredients. J Pediatr Pharmacol Ther. 2017;22(4):314-315. PMCID:PMC5562213  PMID:28943828 
17. Vesoulis ZA, Hao J, McPherson C, El Ters NM, Mathur AM. Low-frequency blood pressure oscillations and inotrope treatment failure in premature infants. J Appl Physiol (1985). 2017;123(1):55-61. PMCID:PMC6157481  PMID:28428252 
18. Luecke C, McPherson C. Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates. Neonatal Netw. 2017;36(3):160-168. PMID:28494828 
19. McPherson C, Smith JR. Analgesia in the Premature Neonate: Walking the Tightrope Requires a Great Team. J Perinat Neonatal Nurs. 2017;31(2):99-100. PMID:28437299 
20. Kalish BT. Management of Neonatal Hypotension. Neonatal Netw. 2017;36(1):40-47. PMID:28137353 
21. Rostas SE, McPherson C. Pharmacist-driven respiratory syncytial virus prophylaxis stewardship service in a neonatal intensive care unit. Am J Health Syst Pharm. 2016;73(24):2089-2094. PMID:27919877 
22. McPherson C. Morphine exposure in preterm infants correlates with impaired cerebellar growth and poorer neurodevelopmental outcome. Evid Based Med. 2016;21(6):234. PMID:27760778 
23. Vesoulis ZA, McPherson C, Neil JJ, Mathur AM, Inder TE. Early High-Dose Caffeine Increases Seizure Burden in Extremely Preterm Neonates: A Preliminary Study. J Caffeine Res. 2016;6(3):101-107. PMCID:PMC5031091  PMID:27679737 
24. Rostas SE, McPherson C. Systemic Corticosteroids for the Prevention of Bronchopulmonary Dysplasia: Picking the Right Drug for the Right Baby. Neonatal Netw. 2016;35(4):234-9. PMID:27461202 
25. Rostas SE, McPherson CC. Pharmacotherapy for Patent Ductus Arteriosus: Current Options and Outstanding Questions. Curr Pediatr Rev. 2016;12(2):110-9. PMID:27197952 
26. McPherson C. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All. Neonatal Netw. 2016;35(5):314-20. PMID:27636696 
27. McPherson C, Haslam M, Pineda R, Rogers C, Neil JJ, Inder TE. Brain Injury and Development in Preterm Infants Exposed to Fentanyl. Ann Pharmacother. 2015;49(12):1291-7. PMCID:PMC4644677  PMID:26369570 
28. McPherson C, Neil JJ, Tjoeng TH, Pineda R, Inder TE. A pilot randomized trial of high-dose caffeine therapy in preterm infants. Pediatr Res. 2015;78(2):198-204. PMCID:PMC4928641  PMID:25856169 
29. Steinhorn R, McPherson C, Anderson PJ, Neil J, Doyle LW, Inder T. Neonatal morphine exposure in very preterm infants-cerebral development and outcomes. J Pediatr. 2015;166(5):1200-1207.e4. PMCID:PMC4928575  PMID:25919729 
30. Ruoss JL, McPherson C, DiNardo J.. Inotrope and vasopressor support in neonates. NeoReviews. 2015;16:e351-e361. 
31. McPherson C, Grunau RE. Neonatal pain control and neurologic effects of anesthetics and sedatives in preterm infants. Clin Perinatol. 2014;41(1):209-27. PMCID:PMC3925313  PMID:24524456 
32. McPherson C, Yaroslaski AM, Luedtke S, Super J.. Probiotic use in the NICCU: What's taking so long? Infant Child Adolesc Nutr. 2014;6:270-272. 
33. Heble DE Jr, McPherson C, Nelson MP, Hunstad DA. Vancomycin trough concentrations in overweight or obese pediatric patients. Pharmacotherapy. 2013;33(12):1273-7. PMID:23798327 
34. McPherson C. Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment? J Pediatr Pharmacol Ther. 2012;17(4):351-64. PMCID:PMC3567888  PMID:23413121 
35. McPherson C, Warner B, Hunstad DA, Elward A, Acosta EP. Oseltamivir dosing in premature infants. J Infect Dis. 2012;206(6):847-50. PMCID:PMC3572879  PMID:22807525 
36. Rao R, Bryowsky K, Mao J, Bunton D, McPherson C, Mathur A. Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus. J Perinatol. 2011;31(7):465-70. PMID:21252965 
37. Wilkerson J, McPherson C, Donze A. Fluconazole to prevent systemic fungal infections in infants: reviewing the evidence. Neonatal Netw. 2010;29(5):323-33. PMID:20829180 
38. McPherson C, Gal P, Ransom JL, Carlos RQ, Dimaguila MA, Smith M, Davonzo C, Wimmer JE Jr. Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability. Pediatr Cardiol. 2010;31(4):505-10. PMID:20063159 
39. McPherson C, Gal P, Smith M, Wilder W, Richter S, Ransom JL, Carlos RQ, Dimaguila MA, Wimmer Jr. JE.. Necrotizing enterocolitis in preterm infants with patent ductus arteriosus: does indomethacin increase the risk? Journal of Neonatal-Perinatal Medicine. 2008;1(4):209-216. 
40. McPherson C, Gal P, Ransom JL. Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant. Ann Pharmacother. 2008;42(7):1134-8. PMID:18577764 
41. Sykes R, McPherson C, Foulks K, Wade J, Gal P. Aminophylline compatibility with neonatal total parenteral nutrition. J Pediatr Pharmacol Ther. 2008;13(2):76-9. PMCID:PMC3462061  PMID:23055868 
42. Gura K, Strijbosch R, Arnold S, McPherson C, Puder M. The role of an intravenous fat emulsion composed of fish oil in a parenteral nutrition-dependent patient with hypertriglyceridemia. Nutr Clin Pract. 2007;22(6):664-72. PMID:18042955 
43. Liviskie CJ, Brennan CC, McPherson CC, Vesoulis ZA. Propranolol for the treatment of lymphatic malformations in a neonate - a case report and review of literature. Journal of Pediatric Pharmacology and Therapeutics. 
44. McPherson C. Neonatal herpes simplex virus: The long road to improved outcomes. Neonatal Network. 
45. Rostas SE, McPherson C. Caffeine therapy in preterm infants: the dose (and timing) make the medicine. Neonatal Network.